ArticleCancer chemotherapy and pharmacology2024

Population pharmacokinetics of TLD-1, a novel liposomal doxorubicin, in a phase I trial.

Anna M Mc Laughlin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.